OH HB39 | 2007-2008 | 127th General Assembly

Status

Spectrum: Partisan Bill (Democrat 11-0)
Status: Introduced on February 20 2007 - 25% progression, died in committee
Action: 2007-02-20 - To Health
Pending: House Health Committee

Summary

To amend section 3715.99 and to enact sections 3715.88, 3715.89, and 3715.90 of the Revised Code to require manufacturers and labelers of dangerous drugs to disclose to the Director of Health the value, nature, and purpose of certain gifts, fees, payments, subsidies, and other economic benefits they provide in connection with pharmaceutical detailing, marketing, or promotion.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Drug manufacturers-disclose marketing incentives

Sponsors


History

DateChamberAction
2007-02-20 To Health
2007-02-20 Introduced to House

Ohio State Sources


Bill Comments

feedback